Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012749
Filing Date
2022-08-09
Accepted
2022-08-09 07:31:33
Documents
57
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20220630x10q.htm   iXBRL 10-Q 1536895
2 EX-31.1 cgtx-20220630xex31d1.htm EX-31.1 16277
3 EX-31.2 cgtx-20220630xex31d2.htm EX-31.2 16787
4 EX-32.1 cgtx-20220630xex32d1.htm EX-32.1 9966
5 EX-32.2 cgtx-20220630xex32d2.htm EX-32.2 10004
  Complete submission text file 0001558370-22-012749.txt   5880832

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20220630.xsd EX-101.SCH 36051
7 EX-101.CAL cgtx-20220630_cal.xml EX-101.CAL 48593
8 EX-101.DEF cgtx-20220630_def.xml EX-101.DEF 117687
9 EX-101.LAB cgtx-20220630_lab.xml EX-101.LAB 390719
10 EX-101.PRE cgtx-20220630_pre.xml EX-101.PRE 275546
51 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20220630x10q_htm.xml XML 965406
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 221146417
SIC: 2836 Biological Products, (No Diagnostic Substances)